Nizatidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171903This classification denotes a histamine-2 receptor antagonist with the molecular formula C12H21N5O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P41PML4GHR, chemically known as 1,1-ethenediamine, n-(2-(((2-((dimethylamino)methyl)-4-thiazoly)methyl)thio)ethyl)-n-methyl-2-nitro- but generally known as nizatidine, which bears US NIH Compound Identifier 3033637. European Medicines Agency schedules Nizatidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09335MIG. The term NIZATIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules nizatidine in its Anatomical Therapeutic Chemical (ATC) Classification. NIZATIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nizatidine under HS 29341000 and SITC 51579. As of Q4 2014, NIZATIDINE remains the US FDA Preferred Term for this commodity. Nizatidine bears US NLM identifiers UMLS ID C0085154 and NCI Concept Code C29295. SMILES: S(CCN/C(=C/[N](=O)O)NC)CC1NC(SC1)CN(C)C.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.